Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010: Clinical Research: Metabolic Syndrome

Objectives This study sought to characterize the prevalence of metabolic syndrome (MetS), its 5 components, and their pharmacological treatment in U.S. adults by sex and race/ethnicity over time. Background MetS is a constellation of clinical risk factors for cardiovascular disease, stroke, kidney d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2013-08, Vol.62 (8), p.697-703
Main Authors: Beltran-Sanchez, Hiram, Harhay, Michael O, Harhay, Meera M, McElligott, Sean
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives This study sought to characterize the prevalence of metabolic syndrome (MetS), its 5 components, and their pharmacological treatment in U.S. adults by sex and race/ethnicity over time. Background MetS is a constellation of clinical risk factors for cardiovascular disease, stroke, kidney disease, and type 2 diabetes mellitus. Methods Prevalence estimates were estimated in adults ( greater than or equal to 20 years of age) from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2010 (in 2-year survey waves). The biological thresholds, defined by the 2009 Joint Scientific Statement, were: 1) waist circumference greater than or equal to 102 cm (males adults) and greater than or equal to 88 cm (female adults); 2) fasting plasma glucose greater than or equal to 100 mg/dl; 3) blood pressure of 130/85 mm Hg; 4) triglycerides greater than or equal to 150 mg/dl; and 5) high-density lipoprotein-cholesterol (HDL-C)
ISSN:0735-1097
DOI:10.1016/j.jacc.2013.05.064